1. Medtech Insight

Nevro Names Kevin Thornal As Its New CEO; Investors Remain Disappointed In Results

 
• By Reed Miller

Thornal will replace Keith Grossman who is retiring. Investors and analysts hope Thornal will help the spinal cord stimulation company reach profitability by growing its “core” chronic pain business.

low back pain
• Source: Alamy

Kevin Thornal will try to lead rapidly growing spinal cord stimulation (SCS) company Nevro to profitability as its new CEO.

Thornal will take over as CEO and president on 24 April, the company announced on 19 April

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Leadership

More from Medtech Insight